The impact of antibiotic (Ab) exposure on clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or VEGF targeted therapy (VEGF-TT).

Matthew Scott Ernst,Sarah Abou Alaiwi,Nazli Dizman,Chris Labaki,Pier Vitale Nuzzo,Elio Adib,Andrew Lachlan Schmidt,Luis Meza,Chun Loo Gan,J. Connor Wells,Ziad Bakouny,Sumanta K. Pal,Toni K. Choueiri,Daniel Yick Chin Heng,Shaan Dudani

The impact of antibiotic (Ab) exposure on clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or VEGF targeted therapy (VEGF-TT).

2021

Matthew Scott Ernst
Sarah Abou Alaiwi
Nazli Dizman
Chris Labaki
Pier Vitale Nuzzo
Elio Adib
Andrew Lachlan Schmidt
Luis Meza
Chun Loo Gan
J. Connor Wells
Ziad Bakouny
Sumanta K. Pal
Toni K. Choueiri
Daniel Yick Chin Heng
Shaan Dudani

4552Background: Retrospective studies have shown an association between Ab exposure and inferior clinical outcomes in patients receiving ICI across various tumor types, including mRCC. However, it ...

Keywords:

Antibiotics
Medicine
Internal medicine
Targeted therapy
Renal cell carcinoma
Oncology
in patient
VEGF receptors
Retrospective cohort study
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations